|
HS Code |
704537 |
| Name | Dehydroepiandrosterone |
| Abbreviation | Dhea |
| Chemical Formula | C19H28O2 |
| Molecular Weight | 288.42 g/mol |
| Cas Number | 53-43-0 |
| Appearance | White crystalline powder |
| Solubility | Slightly soluble in water, soluble in alcohol and ether |
| Biological Role | Precursor hormone for androgens and estrogens |
| Use | Dietary supplement and hormone therapy |
| Production Site | Mainly adrenal glands |
| Half Life | 15-38 minutes in plasma |
| Route Of Administration | Oral, sublingual, topical, intramuscular |
| Legal Status | Over-the-counter in some countries, prescription in others |
As an accredited Dehydroepiandrosterone (Dhea) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White plastic bottle labeled "Dehydroepiandrosterone (DHEA), 100 mg, 100 tablets" with blue accents and safety seal, tamper-evident. |
| Shipping | Dehydroepiandrosterone (DHEA) is shipped in tightly sealed, labeled containers to protect it from moisture, light, and contamination. Packages comply with local and international regulations for handling hormones. Temperature control may be required to ensure product stability during transit. Safety documentation and handling instructions are included with all shipments. |
| Storage | Dehydroepiandrosterone (DHEA) should be stored in a tightly closed container, protected from light, moisture, and heat. Keep it at room temperature, typically between 15–25°C (59–77°F). Store in a cool, dry place away from incompatible substances and out of reach of children. Ensure appropriate labeling and follow all relevant safety and regulatory storage guidelines. |
| Purity 99%: Dehydroepiandrosterone (Dhea) with purity 99% is used in pharmaceutical formulation, where it ensures optimal bioavailability and consistent therapeutic efficacy. Molecular Weight 288.42 g/mol: Dehydroepiandrosterone (Dhea) featuring molecular weight 288.42 g/mol is used in hormone replacement therapy, where it facilitates accurate dosing and predictable physiological response. Melting Point 148-150°C: Dehydroepiandrosterone (Dhea) with melting point 148-150°C is used in tablet manufacturing, where it provides process stability and uniformity during compression. Stability Temperature up to 25°C: Dehydroepiandrosterone (Dhea) stable up to 25°C is used in long-term storage solutions, where it maintains chemical integrity and shelf life. Particle Size <10 µm: Dehydroepiandrosterone (Dhea) with particle size less than 10 µm is used in topical creams, where it enhances skin absorption and local bioactivity. USP Grade: Dehydroepiandrosterone (Dhea) of USP grade is used in regulated medical preparations, where it complies with stringent quality and safety standards. Optical Rotation +68° to +72°: Dehydroepiandrosterone (Dhea) exhibiting optical rotation +68° to +72° is used in chirality-sensitive synthesis, where it assures stereochemical fidelity in end products. Residual Solvent <0.1%: Dehydroepiandrosterone (Dhea) with residual solvent below 0.1% is used in parenteral formulations, where it reduces risk of adverse reactions and increases patient safety. |
Competitive Dehydroepiandrosterone (Dhea) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer with decades of hands-on experience in hormone synthesis and purification, we view dehydroepiandrosterone (DHEA) as one of the more rewarding compounds to produce. Our DHEA has the IUPAC name 3β-hydroxyandrost-5-en-17-one and a molecular formula of C19H28O2. What sets production of DHEA apart from simpler chemicals is the attention required at each stage—starting with raw steroid intermediates followed by multi-step organic transformations. Over the years, controlling impurities such as related steroidal byproducts has become a non-negotiable focus. Our process has evolved to keep levels of known impurities well under typical compendial thresholds, improving both product safety and consistency. Recognizing how the smallest fluctuation can impact the downstream user, we’ve embedded robust analytical controls at every step.
We manufacture DHEA as a white crystalline powder, and our current lot consistently achieves a purity greater than 99.5% by HPLC. Moisture content, measured with Karl Fischer titration, is always kept below 0.5%, minimizing degradation risk during storage and transport. Particle size distribution is tight—most of our material passes a 60-mesh screen. We batch-test microbial content and maintain strict limits for bacteria and fungi, understanding the frequent usage of DHEA in health-related applications. Our product dissolves readily in common organic solvents, including ethanol and methanol, which makes it suitable for many pharmaceutical formulations or compounding uses. This is not always the case with DHEA sourced through less controlled channels where variable crystal habits or poor solubility can affect final product performance. In addition, our DHEA manufacturing keeps heavy metal residues well within established industry recommendations through a combination of process controls and intelligent raw material sourcing. No residual solvents are detected above ICH Q3C guidelines on our COA.
By far, most requests for our DHEA come from companies working in dietary supplements, anti-aging research, and hormone-related studies. Experienced formulators depend on solid batch-to-batch predictability. Our clients rely on our DHEA for filling capsules, tableting, as well as liquid suspensions and topical applications. Some pharmaceutical developers source our DHEA as an intermediate to synthesize other steroid hormones downstream, such as estradiol or testosterone derivatives. Working at this stage, we see firsthand how unanticipated impurities interfere with downstream chemistry. A lower grade DHEA often clogs reactors, changes the kinetics, and ultimately lowers yield on valuable secondary products. We invested in advanced purification to support those customers who require exceptionally clean material for subsequent reactions.
In animal nutrition, DHEA finds use to supplement research studies, particularly for age-related models. Labs and universities have trusted our DHEA thanks to transparency we provide in method development. These users value detailed traceability and direct access to production data—which is only feasible when sourcing straight from the manufacturer.
From a health supplement perspective, our customers often flag lot-to-lot variability when sourcing from indirect suppliers. We handle all blending, quality checks, and packaging in-house to address these complaints. A heavy investment in production records allows us to address specific customer questions about origin, trace sterilization, and handling procedures—not possible when dealing with distribution chains.
Working as a direct producer, we have watched many entrants in the DHEA supply market come and go. An obvious difference appears in the way raw materials are handled. We begin with pharmaceutical-grade diosgenin, which carries less risk of pesticide, mycotoxin, and residual solvent contamination. Some traders accept lower grade intermediates or poorly validated syntheses, but these shortcuts almost always resurface as problems in finished goods. Customers told us about powder lots colored light grey or tan, which often means incomplete purification. We believe crisp color and neutral smell signal proper controls. Impure or oxidized material complicates blending and can trigger compliance failures in regulated markets.
Packaging also matters in real world use. We protect DHEA from light and moisture through multilayer, tamper-proof HDPE liners with heat sealing, extending shelf life and maintaining powder integrity. Bulk shipments for industrial formulators follow strict validated cleaning and filling protocols. Traders and non-manufacturing sources sometimes offer DHEA in repacked bags or through loose networked distribution; this introduces risks of cross-contamination, or exposure to higher humidity, which degrades active content before it reaches the end user.
Comparing our in-house analytics to those performed downstream by customers, we usually see close agreement in DHEA assay and byproduct testing. This provides confidence for formulators who need reliable content for label claims. We have tackled questions about cross-species DNA contamination and deliberate melamine adulteration raised in regulatory audits—demonstrating that not all DHEA on the open market survives intense scrutiny. For products targeted toward OTC pharmaceuticals or nutritional products in regions with active enforcement, producer-origin DHEA carries legal and commercial certainty.
DHEA occupies a complex position in regulations worldwide. Some jurisdictions classify it as a controlled substance; other regions treat it as a food supplement. In response, we maintain separation and traceability for every lot, with regulatory documentation ready to support compliance in both pharmaceutical and supplement pathways. Our site is regularly audited under cGMP and ISO standards, and we provide full traceability including batch numbers, manufacturing dates, and process certificates with every shipment.
We have observed market confusion as traders rebrand lower purity DHEA as “pharmaceutical” grade or fail to disclose source plants. When the origin isn’t clear, customers have reported failed product registrations or unexpected analytical surprises. Operating as the real manufacturer, we’re positioned to provide certificates, process information, and even custom documentation that traders usually can’t deliver. Regulatory needs are different for every jurisdiction—a reality we accommodate by maintaining transparency into our operation, from sourcing to labeling.
We made a clear decision early in our history to source raw intermediates from regions with proven agricultural and environmental stewardship. Our relationships with long-standing suppliers translate to consistent incoming quality and reliability of supply. Supply chain disruptions, such as floods in certain diosgenin-producing regions, directly affect timeline and input costs. We have mitigated these risks, maintaining backup suppliers and stockpiling during peak harvest periods to buffer seasonal shortages. By managing the entire vertical process—from raw plant input right through to packaging—we can deliver predictable, high-quality DHEA to all categories of customers year-round.
We have fielded queries about synthetic versus plant-derived DHEA. Our production relies on plant based starting materials, which keeps heavy metal levels low. Industrial synthetic processes, found with some non-specialist producers, introduce different impurity profiles including organotin residue or chlorinated byproducts.
Producing DHEA with reliable content and minimal impurity is not as simple as a single chemical reaction. The androstenic steroid structure is highly sensitive to oxidation, especially during final crystallization and drying. Early in our manufacturing, we saw significant variability in oxidation byproducts; since then, we’ve adopted strict inert gas blanketing and closed-system drying, which noticeably improved stability—customers soon reported fewer color or solubility complaints.
Subtle process features such as recrystallization solvent choice lead to differences in powder flow, density, and ease of formulation. Our own secondary technical service laboratory runs repeat tests on material flow and compaction, so downstream users save time in blending and pressing. This attention to physical details is sometimes ignored by brokers or contract blenders, but our experience shows it matters in operation.
Quality control labs at major customers routinely test our lots against their own specifications. We share not only COA data, but carry out round-robin testing when needed—especially when customers face re-registration for export, or if changes in regulations prompt new requirements on elemental impurities, residual solvents, or even new DNA barcoding for raw material traceability.
Reports of counterfeit material and adulteration remain a continuing challenge in the global DHEA market. We have detected products labeled as “pure” DHEA which, upon independent lab analysis, contained not only inert fillers but also foreign steroids, even forbidden prohormones designed to cut costs or boost perceived potency. Since we maintain full synthesis in-house, we guarantee nothing dilutes or alters our DHEA from synthesis to final packaged lot. This commitment adds value on the compliance and safety front, and brings peace of mind to our downstream partners.
To help customers independently verify product origin, we provide access to our own retained reference samples for third-party testing. We understand that trust builds with transparency, and we stand ready to respond to technical queries or regulatory sampling at short notice—a level of service not realistically available from non-manufacturers.
Our long-term relationships with research institutes, pharmaceutical developers, and compounding pharmacies show the full impact of consistently made DHEA. In our experience, research teams depend on validated reference standards and need transparent production data—not only purity, but also impurity profiles and stability under actual laboratory storage. By supplying detailed certificates and full method traceability, we equip research users to meet their own publication or regulatory requirements. It helps avoid repeating analytical work, eliminates doubts about lot-to-lot variation, and accelerates project approval when sample material must be referenced in studies. This level of support only works when dealing directly with a factory that knows and controls every detail of its production.
For clinical developers, purity and documentation matter even more. Trace levels of byproducts—undetectable in general food-grade material—can jeopardize safety studies or cause batch failures. By having our DHEA reviewed by both in-house and external quality labs, and keeping real-time stability monitoring of retained samples, we support the high trust requirements of those developing new drug applications or running patient safety monitoring. Our participating in collaborative research lets us stay ahead of shifting regulatory trends and adopt new best practices years before they become industry consensus.
Experience shows that chemical manufacturing only works when there is a clear, direct line between production and end-use. We maintain a dedicated technical support team close to the production floor, not only for compliance but also early-warning troubleshooting. Many customer issues—such as powder bridging during encapsulation, or unexpected dissolution times—trace back to production phase adjustments. By being the actual manufacturer, we can tweak parameters, manage batch blending, and keep open lines with customers through their own test period and up to full-scale commercial use.
We have responded to urgent timelines, supplying pilot batches and rapid scale-ups with full in-house documentation. This flexibility has supported product launches for partners under changing regulatory climates and competitive market pressure—while keeping technical standards intact. Our control over the entire supply chain gives us an honest picture of real-world demands, making us less likely to overpromise or deliver anything we can’t stand behind.
Feedback from the field — whether it comes from pharmaceutical compounding, supplement manufacture, or new research protocols — routinely shapes our approach. Practical changes often emerge: refining particle size spectra to address specific compression or blending requirements; further reducing microbial levels for immuno-sensitive users; and developing bespoke packaging adapted to transport in humid or temperature-variable regions. Since these improvements are informed by real direct user experience, rather than abstract goals, they keep our DHEA at the front of industry performance.
As the landscape of steroid chemistry advances, we see continuous room for improvement in both product design and regulatory support. Increasing calls for sustainability and clean supply lines push us to monitor raw input sourcing, environmental impact, and the downstream effects of packaging. We keep our waste throughput low, recover and recycle solvents, and support agricultural partners in optimizing extraction yields, all while maintaining DHEA purity and content at consistently high benchmarks.
With increased scrutiny from both regulatory bodies and discerning industrial users, we recognize that future trust will hinge on demonstrated integrity—tracing production, certifying inputs, and offering independent validation. Our organization stands ready to show each step, answer detailed technical questions, and adapt to legal and industry changes. Maintaining such flexibility is only possible for the actual producer, not for traders who lack real operational oversight.
From our perspective as a hands-on DHEA manufacturer, product quality, traceability, and technical partnership carry genuine business value that goes beyond any one specification sheet. Customers who work with the true manufacturer have direct answers to formulation issues, secure documentation for registration and compliance, and the reliability that comes from unbroken supply lines in volatile global markets. Whether for dietary supplements, pharmaceutical intermediates, or research, consistent DHEA performance reflects careful attention at every production stage—a promise we make because we control each step ourselves.
Factories like ours set the tone for the modern chemical industry: showing how science, transparency, and practical, customer-driven improvement give users products they can depend on, now and into the future.